AIM2 and melanoma: Immunohistochemistry studies have shown high levels of AIM2 in inflammatory skin disorders (de Koning et al., 2012) and in primary melanoma (de Koning, van Vlijmen‐Willems, Zeeuwen, Blokx, & Schalkwijk, 2014).